MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 21.02.2026
I-Mab P/E 2011-2026 | IMAB
P/E Jährlich I-Mab
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.236 | -0.159 | -3.55 | 13.4 | -0.00798 | -0.034 | -0.0404 | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 13.4 | -3.55 | 1.34 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
124 | $ 20.15 | -2.68 % | $ 2.54 B |  USA |
 |
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
-0.958 | $ 0.82 | -3.48 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
-47.3 | $ 163.7 | -1.61 % | $ 8.14 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
-6.57 | $ 3.72 | -2.75 % | $ 1.11 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Burford Capital Limited
BUR
|
12.2 | $ 8.52 | -2.46 % | $ 1.39 B | Britain |
 |
Corvus Pharmaceuticals
CRVS
|
-3.48 | $ 17.75 | -0.79 % | $ 852 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - |  Russia |
 |
Certara
CERT
|
-676 | $ 7.16 | 1.49 % | $ 1.15 B | USA |
 |
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
-6.97 | $ 25.91 | -3.56 % | $ 694 M | USA |
 |
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | Canada |
 |
Codexis
CDXS
|
-4.46 | $ 0.99 | -3.28 % | $ 72.7 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
14.2 | $ 24.0 | 0.5 % | $ 2.93 B | USA |
 |
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-0.000834 | $ 3.19 | -4.64 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-3.95 | $ 28.78 | -1.44 % | $ 1.67 B | USA |
 |
Champions Oncology
CSBR
|
22.5 | $ 6.0 | -1.15 % | $ 82 M | USA |
 |
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
17.7 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-3.81 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
-1.62 | $ 3.67 | -3.42 % | $ 116 M | France |
 |
Alector
ALEC
|
-1.73 | $ 2.11 | -4.75 % | $ 217 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-4.2 | $ 15.68 | -2.4 % | $ 779 M | Britain |
 |
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
-4.87 | $ 4.17 | 0.24 % | $ 296 M | USA |
 |
Teligent, Inc.
TLGT
|
-0.879 | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-2.83 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | USA |
 |
Amarin Corporation plc
AMRN
|
-150 | $ 14.27 | 2.44 % | $ 5.92 B |  Irlanda |